Actual Experience PLC
LSE:ACT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Actual Experience PLC
LSE:ACT
|
UK |
|
D
|
Dr. Agarwal's Health Care Ltd
NSE:AGARWALEYE
|
IN |
|
T
|
Tien Wah Press Holdings Bhd
KLSE:TIENWAH
|
MY |
|
KBC Groep NV
XBRU:KBC
|
BE |
|
Capital Clean Energy Carriers Corp
NASDAQ:CCEC
|
GR |
|
M
|
Marimekko Oyj
OMXH:MEKKO
|
FI |
|
M
|
Memphasys Ltd
ASX:MEM
|
AU |
|
CLP Holdings Ltd
HKEX:2
|
HK |
|
Lovisa Holdings Ltd
ASX:LOV
|
AU |
|
Fandango Holdings PLC
LSE:FHP
|
UK |
|
F
|
Ffbw Inc
OTC:FFBW
|
US |
|
Cerence Inc
NASDAQ:CRNC
|
US |
|
T
|
Techindia Nirman Ltd
NSE:TECHIN
|
IN |
|
AddLife AB
STO:ALIF B
|
SE |
|
UMT United Mobility Technology AG
XETRA:UMDK
|
DE |
|
Saint-Gobain Sekurit India Ltd
BSE:515043
|
IN |
|
Equasens SA
PAR:EQS
|
FR |
|
Fasadgruppen Group AB (publ)
STO:FG
|
SE |
Income Statement
Earnings Waterfall
Actual Experience PLC
Income Statement
Actual Experience PLC
| Mar-2015 | Sep-2015 | Mar-2016 | Sep-2016 | Mar-2017 | Sep-2017 | Mar-2018 | Sep-2018 | Mar-2019 | Sep-2019 | Mar-2020 | Sep-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||
| Revenue |
1
N/A
|
1
+11%
|
1
+21%
|
1
-16%
|
0
-41%
|
0
-13%
|
0
+20%
|
1
+147%
|
2
+64%
|
2
+10%
|
2
+1%
|
2
+0%
|
2
-4%
|
2
-7%
|
2
-4%
|
1
-29%
|
1
-51%
|
|
| Gross Profit | ||||||||||||||||||
| Cost of Revenue |
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Gross Profit |
0
N/A
|
0
-36%
|
0
-12%
|
(0)
N/A
|
(1)
-223%
|
(1)
-22%
|
(1)
+12%
|
(0)
+89%
|
1
N/A
|
1
+27%
|
1
+14%
|
1
+13%
|
1
-6%
|
1
-13%
|
1
-11%
|
0
-54%
|
(0)
N/A
|
|
| Operating Income | ||||||||||||||||||
| Operating Expenses |
(2)
|
(3)
|
(4)
|
(6)
|
(6)
|
(7)
|
(7)
|
(7)
|
(8)
|
(7)
|
(6)
|
(6)
|
(5)
|
(6)
|
(7)
|
(6)
|
(5)
|
|
| Selling, General & Administrative |
(2)
|
(3)
|
(4)
|
(6)
|
(6)
|
(7)
|
(7)
|
(5)
|
(6)
|
(5)
|
(5)
|
(4)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
(1)
|
(3)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(2)
N/A
|
(2)
-37%
|
(4)
-66%
|
(6)
-50%
|
(7)
-20%
|
(8)
-9%
|
(8)
0%
|
(7)
+6%
|
(7)
+6%
|
(6)
+9%
|
(5)
+15%
|
(5)
+16%
|
(4)
+10%
|
(5)
-24%
|
(7)
-29%
|
(5)
+16%
|
(5)
+5%
|
|
| Pre-Tax Income | ||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(1)
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(2)
N/A
|
(2)
-38%
|
(4)
-65%
|
(6)
-50%
|
(7)
-21%
|
(8)
-9%
|
(8)
+1%
|
(7)
+7%
|
(7)
+5%
|
(6)
+10%
|
(6)
+6%
|
(5)
+14%
|
(4)
+17%
|
(6)
-42%
|
(7)
-11%
|
(5)
+16%
|
(5)
+6%
|
|
| Net Income | ||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(2)
|
(2)
|
(4)
|
(6)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(6)
|
(5)
|
(5)
|
(4)
|
(6)
|
(7)
|
(5)
|
(5)
|
|
| Net Income (Common) |
(2)
N/A
|
(2)
-44%
|
(4)
-70%
|
(6)
-50%
|
(7)
-21%
|
(7)
-8%
|
(7)
+2%
|
(7)
+0%
|
(7)
+2%
|
(6)
+16%
|
(5)
+7%
|
(5)
+14%
|
(4)
+15%
|
(6)
-48%
|
(7)
-12%
|
(5)
+19%
|
(5)
+9%
|
|
| EPS (Diluted) |
-0.05
N/A
|
-0.07
-40%
|
-0.11
-57%
|
-0.15
-36%
|
-0.18
-20%
|
-0.18
N/A
|
-0.16
+11%
|
-0.16
N/A
|
-0.16
N/A
|
-0.13
+19%
|
-0.12
+8%
|
-0.1
+17%
|
-0.08
+20%
|
-0.11
-38%
|
-0.11
N/A
|
-0.09
+18%
|
-0.02
+78%
|
|